Document:

Exhibit 10.1

 

BILL OF SALE, ASSIGNMENT AND ASSUMPTION
AGREEMENT

 

CARDAX PHARMACEUTICALS, INC.

 

as the Assignor

 

and

 

CARDAX PHARMA, INC.

 

as the Assignee

 

Dated:    As of May 31, 2013

 

BILL OF SALE AND ASSIGNMENT:

 

CARDAX PHARMACEUTICALS,
INC., a Delaware corporation (the "Assignor"), for good and valuable consideration the receipt and sufficiency
of which is hereby acknowledged, subject to the terms and provisions of this Bill of Sale, Assignment and Assumption Agreement
(this “instrument”) does hereby and with immediate effect grant, assign, sell, convey, transfer and deliver
(“Transfer”), unto CARDAX PHARMA, INC., a Delaware corporation, and its successors and assigns (the "Assignee")
all of Assignor's right, title and interest in and to all of its assets, properties and rights of the Assignor of every type, character
and description, whether real or personal, tangible or intangible, wherever situated in which the Assignor has any right, title
or interest on and as of the date hereof, including without limitation all cash funds of the Assignor and all rights to receive
cash funds after the date hereof OTHER THAN the assets and rights that are listed on Schedule I, attached hereto (collectively,
the “Excluded Assets”);

 

TO HAVE AND TO HOLD
the same unto the Assignee, its successors and assigns, to and for its use forever. The assets, properties, and rights of the Assignor
being Transferred to the Assignee hereunder are hereinafter referred to as the "Transferred Assets."

 

AND, for the consideration
aforesaid, the Assignor hereby constitutes and appoints the Assignee, its successors and assigns, the true and lawful attorney
or attorneys of the Assignor, with full power of substitution, in its name and stead or otherwise, to demand and receive from time
to time any and all of the Transferred Assets hereby Transferred, and to give receipts and releases for and in respect of the same
and any part thereof, and from time to time to institute and prosecute in the name of the Assignor or otherwise, but at the expense
and for the benefit of the Assignee, its successors and assigns, any and all proceedings at law, in equity or otherwise which the
Assignee, its successors and assigns, may deem proper in order to collect, assert, or enforce any claim, right or title of any
kind in and to the Transferred Assets hereby Transferred, and to defend or compromise any and all actions, suits, or proceedings
in respect of any of the Transferred Assets and to do all such acts and things in relation thereto as the Assignee, its successors
or assigns, shall deem desirable; and the Assignor hereby declares that the appointment made and the powers hereby granted are
coupled with an interest and are and shall be irrevocable by the Assignor in any manner or for any reason;

 

    	 

    	 

    

  

AND, for the consideration
aforesaid, the Assignor for itself and its successors and assigns has covenanted and by this instrument does covenant with the
Assignee, its successors and assigns, that it, the Assignor, and its successors and assigns, will do, execute and deliver, or will
cause to be done, executed and delivered, all such further acts, transfers, assignments, conveyances, powers of attorney and assurances,
for the better assuring, conveying and confirming unto the Assignee, its successors, and assigns, all and singular the entire right,
title and interest in the Transferred Assets hereby Transferred as the Assignee, its successors, or assigns or any surviving corporation
in a merger in which the Assignor is a constituent corporation, shall reasonably require. Without limiting the foregoing, the Assignor
shall as promptly as possible Transfer to the Assignee all cash funds, accounts, instruments or other assets received after the
date of this instrument which relate to services rendered or the conduct of business on or prior to the date of this Agreement
or are in any way otherwise related to any of the Transferred Assets, and all cash funds shall be transferred or paid to the account
or accounts from time to time designated by the Assignee or its successor or assign.

 

The Assignor agrees
to execute, deliver and file such additional instruments and to take such other actions as the Assignee may reasonably request
in order to effectuate the purposes hereof.

 

ASSUMPTION OF LIABILITIES:

 

The Assignee, for good
and valuable consideration the receipt and sufficiency of which is hereby acknowledged, subject to the terms and provisions of
this instrument does hereby and with immediate effect assume and agree to perform and discharge fully and timely, and to pay fully
and timely, in each case, subject to all defenses (in law and in equity), right to set off, credits and other discounts of the
Assignor on the date of this instrument, the following: any and all obligations, debts, and liabilities of any kind of the Assignor,
known or unknown, contingent or otherwise, accrued, accruing or becoming due prior to the date hereof. The obligations, debts,
and liabilities being assumed by the Assignee include, without limitation, obligations, debts, and liabilities owed by the Assignor
on account of, or pursuant to: promissory notes, settlement agreements, leases, joint venture agreements, customer contracts, supply
contracts, trade debt and other payables, insurance policies, permits and licenses of any kind, commitments, arrangements, and
contracts of any kind.

 

OTHER PROVISIONS:

 

This instrument and
the covenants and agreements herein contained shall inure to the benefit of the Assignee, its successors and assigns, and any surviving
corporation or other entity in a merger in which the Assignee is a constituent corporation, and shall be binding upon the Assignor,
its successors and assigns and any surviving corporation or other entity in a merger in which the Assignor is a constituent corporation.
All transfers and assumptions herein shall be deemed with effect on the date first written above.

 

    	- 2 -

    	 

    

  

This instrument and
any and all related instruments of transfer or assignment delivered hereunder, if any, shall be governed by and interpreted in
accordance with the laws of the State of New York applicable to contracts executed and wholly performed within such State.

 

This instrument may
be executed in any number of counterparts, each of which shall be an original, and all of which shall together constitute one instrument.

 

    	- 3 -

    	 

    

  

IN WITNESS WHEREOF,
each of the parties to this instrument has caused this instrument to be duly executed on its behalf by its duly authorized officer
as of the date first written above.

 

	 	THE ASSIGNOR:
	 	 	 
	 	CARDAX PHARMACEUTICALS, INC.
	 	 	 
	 	By:   	/s/ David G. Watumull
	 	Name:	David G. Watumull
	 	Title:	President and CEO
	 	 	 
	 	THE ASSIGNEE:
	 	 	 
	 	CARDAX PHARMA, INC.
	 	 	 
	 	By:	/s/ David G. Watumull
	 	Name:	David G. Watumull
	 	Title:	President and CEO

  

    	- 4 -

    	 

    

 

	ACKNOWLEDGMENT
	
         

        STATE OF HAWAII

         

        COUNTY OF HONOLULU:
	
         

         

        ss.:
	 	 

 

On  May 31, 2013
, before me personally came David G. Watamull, to me known, and known to me to be the individual who executed the foregoing
instrument.

	
         

         
	 
	 	Notary Public

 

[Seal]

 

    	 

    	 

    

 

Schedule I

Excluded Assets

 

		1.	All shares of Assignee owned by Assignor.

		2.	All cash of Assignor.

		3.	All assets or rights whereby the transfer and assignment of such asset or right requires the consent,
approval or authorization of a third party, until such date that such consent, approval or authorization is obtained; provided,
that until such consent, approval or authorization is obtained, the Assignor shall license or otherwise arrange for all rights
and benefits of Assignor to such Excluded Asset to be provided to the Assignee and such license or rights in any such other arrangement
shall be a Transferred Asset under this instrument.Exhibit 10.3

 

CARDAX, INC.

 

2014 EQUITY COMPENSATION PLAN

 

STOCK OPTION AGREEMENT

 

SECTION
1.   KIND OF OPTION.

 

This Option is intended
to be either an incentive stock option intended to meet the requirements of section 422 of the Internal Revenue Code (an "ISO")
or a non-statutory option (an "NQSO"), which is not intended to meet the requirements of an ISO, as indicated in the
Notice of Stock Option Grant. Even if this Option is designated as an ISO, it shall be deemed to be an NQSO to the extent required
by the $100,000 annual limitation under Section 422(d) of the Code.

 

SECTION
2.   VESTING.

 

The shares subject
to this Option shall vest in accordance with the schedule set forth in the Notice of Stock Option Grant.

 

SECTION
3.   TERM.

 

Except as otherwise
set forth in the Notice of Stock Option Grant, your Option will expire in any event at the close of business at Company headquarters
on ten (10) years after the Date of Grant; provided, however, that if your Option is an ISO it will expire five (5) years after
the Date of Grant if you are a Ten-Percent Stockholder of the Company (the "Expiration Date").

 

SECTION
4.   TERMINATION OF SERVICE.

 

Except as otherwise
set forth in the Notice of Stock Option Grant, if your employment or other association with the Company ends for any reason, your
Option, to the extent vested, shall cease to be exercisable in any respect and shall terminate not later than ninety (90) days
following such termination of service with the Company and, for the period it remains exercisable following such termination, shall
be exercisable only to the extent exercisable at the date of your termination of service (and to the extent not then exercisable,
shall terminate as of the date of such termination). Military or sick leave or other bona fide leave shall not be deemed a termination
of employment or other association, provided that it does not exceed the longer of ninety (90) days or the period during
which the your reemployment rights, if any, are guaranteed by statute or by contract.

 

SECTION
5.   EXERCISING YOUR OPTION.

 

To exercise your Option,
you must execute the Notice of Exercise and Common Stock Purchase Agreement (the "Exercise Notice"), attached as Exhibit
A. You must submit this form, together with full payment, to the Company. Your exercise will be effective when it is received by
the Company. If someone else wants to exercise your Option after your death, that person must prove to the Company's satisfaction
that he or she is entitled to do so.

 

    	 

    	 

    

 

SECTION
6.     PAYMENT FORMS.

 

When you exercise your
Option, you must include payment of the Exercise Price for the Shares you are purchasing in cash or cash equivalents. Alternatively,
you may pay all or part of the Exercise Price by surrendering, or attesting to ownership of, Shares already owned by you, unless
such action would cause the Company to recognize any (or additional) compensation expense with respect to the Option for financial
reporting purposes. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at their Fair
Market Value on the date of Option exercise. To the extent that a public market for the Shares exists and to the extent permitted
by applicable law, in each case as determined by the Company, you also may exercise your Option by delivery (on a form prescribed
by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds
to the Company in payment of the aggregate Exercise Price and, if requested, applicable withholding taxes. The Company will provide
the forms necessary to make such a cashless exercise. The Board may permit such other payment forms as it deems appropriate, subject
to applicable laws, regulations and rules.

 

SECTION
7.     TAX WITHHOLDING AND REPORTING.

 

		(a)	You will not be allowed to exercise this Option unless you pay, or make acceptable arrangements
to pay, any taxes required to be withheld as a result of the Option exercise or the sale of Shares acquired upon exercise of this
Option. You hereby authorize withholding from payroll or any other payment due you from the Company or your employer to satisfy
any such withholding tax obligation.

 

		(b)	If you sell or otherwise dispose of any of the Shares acquired pursuant to an ISO on or before
the later of (i) two years after the grant date, or (ii) one year after the exercise date, you shall immediately notify the Company
in writing of such disposition.

 

SECTION
8.     RESALE RESTRICTIONS/MARKET STAND-OFF.

 

In connection with
any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed
under the U.S. Securities Act of 1933, as amended, including the Company's initial public offering, you may be prohibited from
engaging in any transaction with respect to any of the Company's common stock without the prior written consent of the Company
or its underwriters in accordance with the provisions of the Exercise Notice.

 

    	 

    	 

    

 

 

SECTION
9.   TRANSFER OF OPTION.

 

Prior to your death,
only you may exercise this Option. This Option and the rights and privileges conferred hereby cannot be sold, pledged or otherwise
transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar
process. For instance, you may not sell this Option or use it as security for a loan. If you attempt to do any of these things,
this Option will immediately become invalid. You may, however, dispose of this Option in your will. Regardless of any marital property
settlement agreement, the Company is not obligated to honor an Exercise Notice from your spouse or former spouse, nor is the Company
obligated to recognize such individual's interest in your Option in any other way. Notwithstanding the foregoing, however, to the
extent permitted by the Board in its sole discretion, an NQSO may be transferred by you to one or more family members or to a trust
established for your benefit and/or one or more of your family members to the extent permitted by the Plan.

 

SECTION
10.   RETENTION RIGHTS.

 

This Agreement does
not give you the right to be retained by the Company in any capacity. The Company reserves the right to terminate your employment
or other association with the Company at any time and for any reason without thereby incurring any liability to you.

 

SECTION
11.   STOCKHOLDER RIGHTS.

 

Neither you nor your
estate or heirs have any rights as a stockholder of the Company until a certificate for the Shares acquired upon exercise of this
Option has been issued. No adjustments are made for dividends or other rights if the applicable record date occurs before your
stock certificate is issued, except as described in the Plan.

 

SECTION
12.   ADJUSTMENTS.

 

In the event of a stock
split, a stock dividend or a similar change in the Common Stock, the number of Shares covered by this Option and the Exercise Price
per share may be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation
or reorganization in the event the Company is subject to such corporate activity as set forth in the Plan.

 

SECTION
13.   TAX DISCLAIMER.

 

You agree that you
are responsible for consulting your own tax advisor as to the tax consequences associated with your Option. The tax rules governing
options are complex, change frequently and depend on the individual taxpayer's situation. Although the Company will make available
to you general tax information about stock options, you agree that the Company shall not be held liable or responsible for making
such information available to you and any tax or financial consequences that you may incur in connection with your Option.

 

By accepting this Option,
you acknowledge that any tax liability or other adverse tax consequences to you resulting from the grant of the Option will be
the responsibility of, and will be borne entirely by, you. YOU ARE THEREFORE ENCOURAGED TO CONSULT YOUR OWN TAX ADVISOR BEFORE
ACCEPTING THE GRANT OF THIS OPTION.

 

SECTION
14.   THE PLAN AND OTHER AGREEMENTS.

 

The text of the Plan
is incorporated in this Agreement by reference. Certain capitalized terms used in this Agreement are defined in the Plan. The Notice
of Stock Option Grant, this Agreement, including its attachments, and the Plan constitute the entire understanding between you
and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

 

    	 

    	 

    

 

SECTION
15.    MISCELLANEOUS PROVISIONS.

 

		(a)	You understand and acknowledge that (i) the Plan is entirely discretionary, (ii) the Company and
your employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not
in any way create any contractual or other right to receive additional grants of options (or benefits in lieu of options) at any
time or in any amount, and (iv) all determinations with respect to any additional grants, including (without limitation) the times
when options will be granted, the number of Shares offered, the Exercise Price and the vesting schedule, will be at the sole discretion
of the Company.

 

		(b)	The value of this Option shall be an extraordinary item of compensation outside the scope of your
employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating
severance, resignation, redundancy or end-of-service payments, bonuses, long service awards, pension or retirement benefits or
similar payments.

 

		(c)	You understand and acknowledge that participation in the Plan ceases upon termination of your employment
or association with the Company for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement.

 

		(d)	You hereby authorize and direct your employer to disclose to the Company or any Subsidiary any
information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation
in the Plan, as your employer deems necessary or appropriate to facilitate the administration of the Plan.

 

    	 

    	 

    

  

		(e)	You consent to the collection, use and transfer of personal data as described in this Subsection.
You understand and acknowledge that the Company, your employer and the Company's other Subsidiaries hold certain personal information
regarding you for the purpose of managing and administering the Plan, including (without limitation) your name, home address, telephone
number, date of birth, social security number, salary, nationality, job title, any Shares or directorships held in the Company
and details of all options or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in
the your favor (the "Data"). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer
Data among themselves as necessary for the purpose of implementation, administration and management of your participation in the
Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the
implementation, administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located
in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic
or other form, for the purpose of administering your participation in the Plan, including a transfer to any broker or other third
party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the administration of the
Plan and/or the subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications
of Data or withdraw the consents set forth in this Subsection by contacting the Human Resources Department of the Company in writing.

 

SECTION
16.    APPLICABLE LAW.

 

This Agreement will be
interpreted and enforced under the laws of the State of Delaware (without regard to their choice of law provisions).

 

 

    	 

    	 

    

 

EXHIBIT A

CARDAX, INC. 2014 EQUITY COMPENSATION
PLAN

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE
AGREEMENT

 

THIS AGREEMENT
is dated as of   ,             , 20__ between Cardax, Inc. (the "Company"), and __________________
(“Purchaser”).

 

WITNESSETH:

 

WHEREAS, the
Company granted Purchaser a stock option on February 7, 2014 (the "Date of Grant") pursuant to a stock option agreement
(the "Option Agreement") under which Purchaser has the right to purchase up to   ______ shares of the
Company's common stock (the "Option Shares"); and

 

WHEREAS, the
Option is exercisable with respect to certain of the Option Shares as of the date hereof, and

 

WHEREAS, pursuant
to the Option Agreement, Purchaser desires to purchase shares of the Company as herein described, on the terms and conditions set
forth in this Agreement, the Option Agreement and the Cardax, Inc. 2014 Equity Compensation Plan (the "Plan"). Certain
capitalized terms used in this Agreement are defined in the Plan.

 

NOW, THEREFORE,
it is agreed between the parties as follows:

 

SECTION
1.     PURCHASE OF SHARES.

 

		(a)	Pursuant to the terms of the Option Agreement, Purchaser hereby agrees to purchase from the Company
and the Company agrees to sell and issue to Purchaser ______ shares of the Company's common stock (the "Common Stock")
for the Exercise Price per share specified in the Notice of Stock Option Grant payable by personal check, cashier's check, money
order or otherwise as permitted by the Option Agreement. Payment shall be delivered at the Closing, as such term is defined below.

 

		(b)	The closing (the "Closing") under this Agreement shall occur at the offices of the Company
as of the date hereof, or such other time and place as may be designated by the Company (the "Closing Date").

 

SECTION
2.     PURCHASER'S INVESTMENT REPRESENTATIONS.

 

This
Agreement is made with Purchaser in reliance upon Purchaser's representation to the Company, which by Purchaser's acceptance hereof
Purchaser confirms, that the Common Stock which Purchaser will receive will be acquired with Purchaser's own funds for investment
for an indefinite period for Purchaser's own account, not as a nominee or agent, and not with a view to the sale or distribution
of any part thereof, and that Purchaser has no present intention of selling, granting participation in, or otherwise distributing
the same, but subject, nevertheless, to any requirement of law that the disposition of Purchaser's property shall at all times
be within Purchaser's control. By executing this Agreement, Purchaser further represents that Purchaser does not have any contract,
understanding or agreement with any person to sell, transfer, or grant participation to such person or to any third person, with
respect to any of the Common Stock.

 

    	 

    	 

    

 

SECTION
3.     RIGHTS OF PURCHASER.

 

		(a)	Except as otherwise provided herein, Purchaser shall, during the term of this Agreement, exercise
all rights and privileges of a stockholder of the Company with respect to the Common Stock.

 

		(b)	Nothing in this Agreement shall be construed as a right by Purchaser to be retained by the Company,
or a parent or subsidiary of the Company in any capacity. The Company reserves the right to terminate Purchaser's employment or
other association with the Company at any time and for any reason without thereby incurring any liability to Purchaser.

 

SECTION
4.     RESALE RESTRICTIONS/MARKET STAND-OFF.

 

Purchaser hereby agrees
that in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration
statement filed under the Securities Act, including the Company's initial public offering, Purchaser shall not, directly or indirectly,
engage in any transaction prohibited by the underwriter, or sell, make any short sale of, contract to sell, transfer the economic
risk of ownership in, loan, hypothecate, pledge, grant any option for the purchase of, or otherwise dispose or transfer for value
or agree to engage in any of the foregoing transactions with respect to any Common Stock without the prior written consent of the
Company or its underwriters, for such period of time after the effective date of such registration statement as may be requested
by the Company or such underwriters. Such period of time shall not exceed one hundred eighty (180) days and may be required by
the underwriter as a market condition of the offering; provided, however, that if either (a) during the last seventeen (17) days
of such one hundred eighty (180) day period, the Company issues an earnings release or material news or a material event relating
to the Company occurs or (b) prior to the expiration of such one hundred eighty (180) day period, the Company announces that it
will release earnings results during the sixteen (16) day period beginning on the last day of the one hundred eighty (180) day
period, then the restrictions imposed during such one hundred eighty (180) day period shall continue to apply until the expiration
of the eighteen (18) day period beginning on the issuance of the earnings release or the occurrence of the material news or material
event; provided, further, that in the event the Company or the underwriter requests that the one hundred eighty (180) day period
be extended or modified pursuant to then-applicable law, rules, regulations or trading policies, the restrictions imposed during
the one hundred eighty (180) day period shall continue to apply to the extent requested by the Company or the underwriter to comply
with such law, rules, regulations or trading policies. Purchaser hereby agrees to execute and deliver such other agreements as
may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to
give further effect thereto. To enforce the provisions of this Section, the Company may impose stop-transfer instructions with
respect to the Common Stock until the end of the applicable stand-off period.

 

    	 

    	 

    

 

SECTION
5.   OTHER NECESSARY ACTIONS.

 

The parties agree to
execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this
Agreement.

 

SECTION
6.   NOTICE.

 

Any notice required
or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon the earliest of personal
delivery, physical receipt (electronically or otherwise) or the third full day following deposit in the United States Post Office
with postage and fees prepaid, addressed to the other party hereto at the address last known or at such other address as such party
may designate by ten (10) days' advance written notice to the other party hereto.

 

SECTION
7.    SUCCESSORS AND ASSIGNS.

 

This Agreement shall
inure to the benefit of the successors and assigns of the Company and be binding upon Purchaser and Purchaser's heirs, executors,
administrators, successors and assigns. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of
any other or subsequent breach or condition, whether of a like or different nature.

 

SECTION
8.   APPLICABLE LAW.

 

This Agreement shall
be governed by, and construed in accordance with, the laws of the State of Delaware, as such laws are applied to contracts entered
into and performed in such state.

 

SECTION
9.   NO ORAL MODIFICATION.

 

No modification of
this Agreement shall be valid unless made in writing and signed by the parties hereto.

 

SECTION
10.   ENTIRE AGREEMENT.

 

This Agreement, the
Option Agreement and the Plan constitute the entire complete and final agreement between the parties hereto with regard to the
subject matter hereof.

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the day and year first above written.

 

	CARDAX, INC.	(PURCHASER)
	 	 
	By:_____________________	_________________________
	Name:	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]